Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 22, 2022
Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2Philippe Garot, Antoinette Neylon, Marie-Claude Morice, et al.Lancet (London, England)|November 6, 2017
Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trialOlivier Varenne, Stéphane Cook, Georgios Sideris, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 21, 2022
Permanent pacemaker implantation and left bundle branch block with self-expanding valves - a SCOPE 2 subanalysisCostanza Pellegrini, Philippe Garot, Marie-Claude Morice, et al.European Heart Journal|May 4, 2018
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusionsGerald S Werner, Victoria Martin-Yuste, David Hildick-Smith, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 8, 2020
Two-year outcomes after percutaneous coronary intervention with drug-eluting stents or bare-metal stents in elderly patients with coronary artery diseaseAlexandre Lafont, Peter R Sinnaeve, Thomas Cuisset, et al.The New England Journal of Medicine|March 12, 2013
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarctionPaul W Armstrong, Anthony H Gershlick, Patrick Goldstein, et al.American Journal of Respiratory and Critical Care Medicine|May 4, 2019
Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled TrialKristina Vermeersch, Maria Gabrovska, Joseph Aumann, et al.Circulation. Cardiovascular Interventions|December 17, 2024
Pharmaco-Invasive Strategy With Half-Dose Tenecteplase in Patients With STEMI: Prespecified Pooled Analysis of Patients Aged ≥75 Years in STREAM-1 and 2Kevin R Bainey, Robert C Welsh, Yinggan Zheng, et al.Circulation|July 13, 2023
STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label TrialFrans Van de Werf, Arsen D Ristić, Oleg V Averkov, et al.American Heart Journal|September 5, 2024
Low-dose colchicine for the prevention of cardiovascular events after percutaneous coronary intervention: Rationale and design of the COL BE PCI trialEmmanuel De Cock, Shakeel Kautbally, Frank Timmermans, et al.Pageof 9